Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug-July 2024-www.financetom.com

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

May 26, 2025 10:36 AM

May 19 (Reuters) - Pfizer ( PFE ) has signed a licensing

agreement worth up to $6 billion with Chinese pharmaceutical

products developer 3SBio Inc ( TRSBF ) for the development,

manufacturing and commercialization of a drug undergoing trials

for treatment of certain types of cancer and tumours, the U.S.

drugmaker said on Monday.

Previous page： Revolut valued at $75 billion in latest share sale Next page： Italian luxury group Zegna names Tagliabue as new group CEO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Revolut valued at $75 billion in latest share sale

Nov 24, 2025

* London-based Revolut valued at $45 billion last year * Nvidia's ( NVDA ) venture arm, Coatue, Greenoaks, Fidelity among investors * Revolut still waiting for full UK banking licence (Writes through with details of the share sale, context and CEO quote from paragraph 3 onwards) By Tommy Reggiori Wilkes LONDON, Nov 24 (Reuters) - Britain's Revolut said on Monday...

Italian luxury group Zegna names Tagliabue as new group CEO

Nov 24, 2025

Nov 24 (Reuters) - Italian luxury group Ermenegildo Zegna ( ZGN ) on Monday named Gianluca Tagliabue as its new CEO, effective January 1. Tagliabue is currently the group's finance chief. The company also named Edoardo and Angelo Zegna, members of the fourth generation of the Zegna family, as co-chief executive officers of the Zegna brand. ...

Why Is Diginex Stock Soaring Monday?

Nov 24, 2025

Diginex Limited ( DGNX ) stock jumped Monday after the sustainability tech firm moved to acquire The Remedy Project, a deal that positions the company at the center of tightening global human-rights rules. The planned acquisition would merge Diginex's ( DGNX ) AI-driven compliance tools with Remedy's on-the-ground grievance and remediation systems, giving enterprises a unified platform to meet fast-approaching...

Performance Food Group, US Foods End Merger Talks

Nov 24, 2025

06:37 AM EST, 11/24/2025 (MT Newswires) -- Performance Food Group ( PFGC ) announced on Monday that it and US Foods ( USFD ) have agreed to cease sharing information and will no longer explore a potential merger. PFGC reiterated its fiscal Q2 net sales guidance of $16.4 billion to $16.7 billion. It also reaffirmed fiscal 2026 net sales guidance...